ProPhase Labs, Inc. (PRPH) stock
PRPHOTCPharmaceutical PreparationsFiscal year ends December 31
$0.01−0.00 (-6.16%)
Close on Oct 19, 2026Market cap $119.68KP/E –Yield –
ProPhase Labs operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
ProPhase Labs's operating cash flow for the twelve months ending Jun 30, 2026 was -$5.54M. For fiscal 2025 it was -$8.34M. The highest annual figure on record is $28.55M in fiscal 2022.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$8.34M | – |
| FY2024 | Dec 31, 2024 | -$17.54M | – |
| FY2023 | Dec 31, 2023 | -$11.89M | -141.6% |
| FY2022 | Dec 31, 2022 | $28.55M | – |
| FY2021 | Dec 31, 2021 | -$13.62M | – |
| FY2020 | Dec 31, 2020 | -$2.59M | – |
| FY2019 | Dec 31, 2019 | -$841.00K | – |
| FY2018 | Dec 31, 2018 | -$2.12M | – |
| FY2017 | Dec 31, 2017 | -$2.84M | – |
| FY2016 | Dec 31, 2016 | -$472.00K | – |
| FY2015 | Dec 31, 2015 | -$3.50M | – |
| FY2014 | Dec 31, 2014 | -$3.22M | -382.8% |
| FY2013 | Dec 31, 2013 | $1.14M | – |
| FY2012 | Dec 31, 2012 | -$5.73M | – |
| FY2011 | Dec 31, 2011 | -$2.11M | – |
| FY2010 | Dec 31, 2010 | -$3.55M | -897.5% |
| FY2009 | Dec 31, 2009 | $445.00K | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$78.00K | – |
| Q1 FY2026 | Mar 31, 2026 | -$748.00K | – |
| Q4 FY2025 | Dec 31, 2025 | -$1.23M | – |
| Q3 FY2025 | Sep 30, 2025 | -$3.49M | – |
| Q2 FY2025 | Jun 30, 2025 | -$247.00K | – |
| Q1 FY2025 | Mar 31, 2025 | -$3.38M | – |
| Q4 FY2024 | Dec 31, 2024 | -$3.52M | – |
| Q3 FY2024 | Sep 30, 2024 | -$4.04M | – |
| Q2 FY2024 | Jun 30, 2024 | -$4.84M | – |
| Q1 FY2024 | Mar 31, 2024 | -$5.14M | -1179.8% |
| Q4 FY2023 | Dec 31, 2023 | -$753.00K | -192.8% |
| Q3 FY2023 | Sep 30, 2023 | -$4.65M | -276.8% |
| Q2 FY2023 | Jun 30, 2023 | -$6.96M | -244.3% |
| Q1 FY2023 | Mar 31, 2023 | $476.00K | -97.7% |
| Q4 FY2022 | Dec 31, 2022 | $811.00K | – |
| Q3 FY2022 | Sep 30, 2022 | $2.63M | – |
| Q2 FY2022 | Jun 30, 2022 | $4.82M | +8.5% |
| Q1 FY2022 | Mar 31, 2022 | $20.29M | – |
| Q4 FY2021 | Dec 31, 2021 | -$4.65M | – |
| Q3 FY2021 | Sep 30, 2021 | -$5.52M | – |
| Q2 FY2021 | Jun 30, 2021 | $4.44M | +1.6% |
| Q1 FY2021 | Mar 31, 2021 | -$7.89M | -2869.1% |
| Q4 FY2020 | Dec 31, 2020 | -$6.77M | – |
| Q3 FY2020 | Sep 30, 2020 | -$481.00K | – |
| Q2 FY2020 | Jun 30, 2020 | $4.37M | – |
| Q1 FY2020 | Mar 31, 2020 | $285.00K | -79.7% |
| Q4 FY2019 | Dec 31, 2019 | -$428.00K | – |
| Q3 FY2019 | Sep 30, 2019 | -$889.00K | – |
| Q2 FY2019 | Jun 30, 2019 | -$927.00K | -818.6% |
| Q1 FY2019 | Mar 31, 2019 | $1.40M | – |
| Q4 FY2018 | Dec 31, 2018 | -$781.00K | – |
| Q3 FY2018 | Sep 30, 2018 | -$1.30M | – |
| Q2 FY2018 | Jun 30, 2018 | $129.00K | – |
| Q1 FY2018 | Mar 31, 2018 | -$166.00K | -105.5% |
| Q4 FY2017 | Dec 31, 2017 | -$1.73M | -533.7% |
| Q3 FY2017 | Sep 30, 2017 | -$445.00K | – |
| Q2 FY2017 | Jun 30, 2017 | -$3.67M | – |
| Q1 FY2017 | Mar 31, 2017 | $3.01M | – |
| Q4 FY2016 | Dec 31, 2016 | $398.00K | – |
| Q3 FY2016 | Sep 30, 2016 | -$682.00K | – |
See a number that looks wrong?